With the race to develop an effective vaccine becoming intense, how has the coronavirus pandemic changed the pharmaceutical industry, and what can we expect in the long- and short-term? Let's…
To remain successful in the oncology market- change is now a key to adapt to this altering market dynamics. A recent development in science and technology platforms are likely to…
In a recent interview with PharmaShots, Dr. Neil Collinson, the Senior Principal Clinical Development Scientist at Genentech / Roche shares his insights and highlights on Xofluza.
Shots:
The P-III BLOCKSTONE…
The US FDA has approved multiple NDAs and BLAs in Aug 2020, leading to treatments for patients and advances in the health care industry. The Center for Drug Evaluation and…
In late 2019, a mysterious virus causing infection consisting of dry cough, fever tiredness, and last pneumonia first appeared in Wuhan, China. The world health organization (WHO) named the disease…
The US FDA has accepted the sBLA for a new self-administration option for Xolair (omalizumab) across all approved US indications.
In an interview with PharmaShots, Ted Omachi the Global Development…
Biosimilars are developed to be highly similar versions of approved biologics in terms of safety, purity, and potency
Mylan with its partner Lupin and Biocon launched Nepexto (biosimilar, etanercept) and…
The US FDA has approved multiple NDAs and BLAs in July 2020, leading to treatments for patients and advances in the health care industry. The Center for Drug Evaluation and…
K. K. Consulting Services has conducted this survey by contacting around 2200 medical representatives across the India using google forms.
Objective of Survey
The purpose of this survey is to design a platform…
The recent decades have shown an accelerated development and evolution in the technology world- leading to unexpected growth in digital health companies.
With the aid of health information technology- wearable…